Literature DB >> 15004169

Architectural changes in the TCR:CD3 complex induced by MHC:peptide ligation.

Nicole L La Gruta1, Haiyan Liu, Smaroula Dilioglou, Michele Rhodes, David L Wiest, Dario A A Vignali.   

Abstract

A hallmark of T cell activation is the ligation-induced down-modulation of the TCR:CD3 complex. However, little is known about the molecular events that drive this process. The CD3 zeta-chain has been shown to play a unique role in regulating the assembly, transport, and cell surface expression of the TCR:CD3 complex. In this study we have investigated the relationship between CD3zeta and the TCRalphabetaCD3epsilondeltagamma complex after ligation by MHC:peptide complexes. Our results show that there is a significant increase in free surface CD3zeta, which is not associated with the TCR:CD3 complex, after T cell stimulation. This may reflect dissociation of CD3zeta from the TCRalphabetaCD3epsilondeltagamma complex or transport of intracellular CD3zeta directly to the cell surface. We also show that MHC:peptide ligation also results in exposure of the TCR-associated CD3zeta NH2 terminus, which is ordinarily buried in the complex. These observations appears to be dependent on Src family protein tyrosine kinases, which are known to be critical for efficient T cell activation. These data suggest a mechanism by which ligated TCR may be differentiated from unligated TCR and selectively down-modulated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004169     DOI: 10.4049/jimmunol.172.6.3662

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Cells diversify transmembrane signaling through the controlled chaos of protein disorder.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2011-04-01

2.  The receptor deformation model of TCR triggering.

Authors:  Zhengyu Ma; Paul A Janmey; Terri H Finkel
Journal:  FASEB J       Date:  2007-11-05       Impact factor: 5.191

3.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

4.  Src-like adaptor protein down-regulates T cell receptor (TCR)-CD3 expression by targeting TCRzeta for degradation.

Authors:  Margaret D Myers; Leonard L Dragone; Arthur Weiss
Journal:  J Cell Biol       Date:  2005-07-18       Impact factor: 10.539

5.  Novel tools to dissect the dynamic regulation of TCR signaling by the kinase Csk and the phosphatase CD45.

Authors:  Ying Xim Tan; Julie Zikherman; Arthur Weiss
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2013-10-07

6.  Association between the expression of IL-10 and T cell activation proteins loss in early breast cancer patients.

Authors:  Leticia Llanes-Fernández; Maria del Carmen Arango-Prado; Juan Manuel Alcocer-González; Marta Elena Guerra-Yi; Sonia Franco-Odio; Rolando Camacho-Rodríguez; Vicente Madrid-Marina; Reyes Tamez-Guerra; Cristina Rodríguez-Padilla
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-24       Impact factor: 4.553

7.  The T Cell Antigen Receptor α Transmembrane Domain Coordinates Triggering through Regulation of Bilayer Immersion and CD3 Subunit Associations.

Authors:  Kristine N Brazin; Robert J Mallis; Andras Boeszoermenyi; Yinnian Feng; Akihiro Yoshizawa; Pedro A Reche; Pavanjeet Kaur; Kevin Bi; Rebecca E Hussey; Jonathan S Duke-Cohan; Likai Song; Gerhard Wagner; Haribabu Arthanari; Matthew J Lang; Ellis L Reinherz
Journal:  Immunity       Date:  2018-10-30       Impact factor: 31.745

8.  What maintains the high intra-follicular estradiol concentration in pre-ovulatory follicles?

Authors:  Yaakov Bentov; Andrea Jurisicova; Shlomit Kenigsberg; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2015-11-09       Impact factor: 3.412

9.  Twisting tails exposed: the evidence for TCR conformational change.

Authors:  Susan E Levin; Arthur Weiss
Journal:  J Exp Med       Date:  2005-02-21       Impact factor: 14.307

10.  Surface-anchored monomeric agonist pMHCs alone trigger TCR with high sensitivity.

Authors:  Zhengyu Ma; Kim A Sharp; Paul A Janmey; Terri H Finkel
Journal:  PLoS Biol       Date:  2008-02       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.